We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Apervita Stock

Invest in or calculate the value of your shares in Apervita or other pre-IPO companies through EquityZen's platform.

Get Started

Apervita Stock

Apervita is a platform that enables the digitalization of massive amounts of health analytics at once.

About Apervita Stock

Founded

2011

Total Funding

21.0M

Industries

Software, Data and Analytics, Artificial Intelligence

Apervita, Inc., formerly known as Pervasive Health, is a platform that enables the digitalization of massive amounts of health analytics at once. Health enterprises use Apervita technologies to turn their medical intellectual property to computable content which in turn can be commercialized globally through the company’s market. Professionals can browse through a broad selection of curated medical content, subscribe to it, connect their own data sets, and publish results into their workflow. The available content covers clinical, operational, and financial use cases, including readmission prevention, chronic disease management, protocol compliance, rapid detection of patient health deterioration, infection early warnings, health complication risks, missing diagnosis detection, problem list improvement, triage prediction, and personal medical device assessment. The HIPAA secure platform supports open standards and can be connected through modern web services to EMRs, portals, and point-of-care systems. Apervita, Inc. was founded in January 2011 and is based in Chicago, Illinois.

Apervita Management

Leadership team at Apervita

Chief Financial Officer

Geoff Phillips

Co-Founder and Chief Executive Officer

Paul Magelli

Locked Features

Join now and verify your accreditation status to gain access to:

  • Apervita current valuation
  • Apervita stock price
  • Available deals in Apervita and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Apervita stock?

Accredited investors can buy pre-IPO stock in companies like Apervita through EquityZen funds. These investments are made available by existing Apervita shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Apervita stock?

Shareholders can sell their Apervita stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."